Research Article
COVID-19 Infection Clinical Profile, Management, Outcome, and Antibody Response in Kidney Transplant Recipients: A Single Centre Experience
Table 2
Laboratory investigations in kidney transplant recipients with COVID-19.
| | Laboratory investigation | Number (N) | Mean (SD) | Min–max |
| | Oxygen saturation (SpO2; %) | 67 | 93.36 (5.4) | 75–99 | | Lymphocyte (×109/L) | 64 | 12.68 (7.38) | 1.0–45.70 | | Haemoglobin (gm%; Hb) | 67 | 11.14 (2.05) | 6.7–15.25 | | Total leucocyte count (TLC; cells/mm3) | 67 | 9999 (4032) | 4367–21433 | | Platelet count (×109/L) | 67 | 203.5 (76.5) | 37.3–391 | | Blood urea (mg/dL) | 67 | 77.27 (38.3) | 21.06–178.0 | | Serum creatinine (mg/dL) | 66 | 2.04 (1.31) | 0.78–6.47 | | Aspartate aminotransferase (AST) (IU/L) | 61 | 30.32 (11.62) | 11.5–72.0 | | Alanine aminotransferase (ALT; IU/L) | 62 | 33.86 (18.7) | 8.0–93.5 | | Serum albumin (gm/dL) | 63 | 3.55 (0.64) | 1.8–4.7 | | Glycosylated haemoglobin (HBA1c; %) | 31 | 7.08 (1.58) | 5.0–11.9 |
|
|
